Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 14, 2024

SELL
$3.17 - $7.91 $6,340 - $15,820
-2,000 Closed
0 $0
Q3 2022

Feb 14, 2024

SELL
$20.09 - $35.8 $7,031 - $12,529
-350 Reduced 14.89%
2,000 $42 Million
Q1 2022

Feb 14, 2024

BUY
$36.48 - $52.22 $85,727 - $122,717
2,350 New
2,350 $96.5 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $443M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.